PureWine

Regulation Crowdfunding offering on SeedInvest (SI Securities)

$344,709

of $1.07M goal

32.2% funded

About the offering

PureWine helps alleviate wine intolerance by filtering some components in wine linked to these common symptoms: headaches, congestion, skin flush, upset stomach. The Mission & Vision - Wine Intolerance is a big problem hiding in plain sight! We estimate that 36 million U.S. adults 21+ (43% of the wine drinking population*) suffer moderate to frequent side effects from drinking wine. The mission of PureWine is to end the problem of wine intolerance and enable more people to enjoy the unique pleasures and health benefits of wine. The Problem - The most common side effects from drinking wine are a function of an individual’s genetics, age, and lifestyle. The cause of some immediate side effects may not be the alcohol, but rather the histamines and the sulfites that are in all red, white, rosé, and sparkling wines. The Solution - PureWine products work by removing the four kinds of histamines and the two kinds of sulfites which trigger some of the common side effects from drinking wine. Importantly, PureWine products work without significantly changing the taste, aromas, or color of wine**.

FAQ

How much has PureWine raised?

PureWine has raised $344,709 of a $1.07M goal.

Where is PureWine's campaign listed?

The offering is listed on SeedInvest (SI Securities), an SEC-registered Reg CF intermediary.

What are the terms of PureWine's raise?

Crowd Note, $17M cap, 20% discount, 8% interest, 24-month term.

When does PureWine's offering close?

The stated close date is Feb 1, 2019.